Merck’s $10B Verona Deal: A High-Stakes Play in Respiratory Care
Verona Pharma plc (NASDAQ:VRNA) is one of the best multibagger stocks according to hedge funds. On July 9, 2025, Merck & Co.
Verona Pharma Plc (VRNA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tyro Capital Management Dan Mcmurtrie | 214,719 | $20,308,123 | 7.97% | |
| 2. | ZWEIG DIMENNA PARTNERS Joe Dimenna | 74,250 | $7,022,565 | 0.66% | |
| 3. | Dorset Management David M. Knott | 55,000 | $5,201,900 | -38% | 2.36% |
| 4. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 47,100 | $4,454,718 | +36% | 1.91% |
| 5. | Greenland Capital Management Michael Englander | 22,000 | $2,080,760 | +47% | 0.21% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.44 | 20,000 | $88,800.00 | 940,003 | 2024-11-18 | Filing | |
| $4.80 | 39,360 | $188,880.77 | 920,003 | 2024-11-06 | Filing | |
| $4.74 | 41,880 | $198,385.56 | 41,880 | 2024-11-06 | Filing | |
| $2.87 | 36,000 | $103,320.00 | 880,643 | 2024-08-12 | Filing | |
| $1.84 | 33,736 | $61,973.03 | 144,800 | 2023-11-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.14 | 10,808 | $142,057.11 | 79,776 | 2025-08-01 | Filing | |
| $13.14 | 9,464 | $124,391.98 | 84,856 | 2025-08-01 | Filing | |
| $13.14 | 9,584 | $125,969.22 | 417,903 | 2025-08-01 | Filing | |
| $13.14 | 208,912 | $2,745,876.65 | 12,464,968 | 2025-08-01 | Filing | |
| $13.14 | 58,336 | $766,750.88 | 2,607,472 | 2025-08-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 839,159 | $79,367,658 | 0.05% | |
| 2. | 607,996 | $57,504,262 | 3.1% | |
| 3. | 526,296 | $47,619,262 | 0.08% | |
| 4. | 493,603 | $46,684,972 | 0.67% | |
| 5. | 225,582 | $21,335,546 | 0.02% |
News See All
14 Best Multibagger Stocks to Buy According to Hedge Funds
The market in 2025 is primed for multibagger opportunities—and it’s not just tech carrying the load.
Verona Pharma (VRNA) Jumps 125% YTD; Merck $10-Billion Acquisition Bolsters Sentiment
Verona Pharma has seen its stock price jump by 125 percent year-to-date, closing at $104.74 versus $46.44 in the last trading day of 2024, with its recent rally largely bolstered by Merck & Co.
Verona Pharma plc (VRNA) Is Unlikely To Face Antitrust Action For Merck Deal, Says Jim Cramer
Verona Pharma plc (NASDAQ:VRNA)’s shares experienced a boost in July when pharmaceutical giant Merck announced that it would acquire the firm for a $10 billion price tag.
Verona Pharma plc (VRNA): A Bull Case Theory
We came across a bullish thesis on Verona Pharma plc (VRNA) on Capital Employed’s Substack by Patients Capital Management. In this article, we will summarize the bulls’ thesis on VRNA.
Jim Cramer Analyzed These 9 Stocks As He Said Tariffs Are Better Than CIA Coups
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed President Trump's tariffs and their impact on the economy and America's global politics.
Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition
Verona Pharma plc (NASDAQ:VRNA) is a small biotechnology company that focuses on respiratory diseases.
14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the recent Bitcoin price jumps.
Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck
In a statement, Merck said that it entered into a definitive agreement with Verona Pharma plc (NASDAQ:VRNA), under which the former, through its subsidiary, will acquire the company’s American Depositary...
Piper Sandler Lifts PT on Verona Pharma (VRNA) Stock, Maintains Overweight
Verona Pharma plc (NASDAQ:VRNA) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.
Billionaire Hedge Funds
